Back
Karyopharm Therapeutics Stock Price Chart
Major Market Shift - Act Now Before it's Too Late
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
KPTI
Karyopharm Therapeutics
Last Price:
$5.59
Seasonality Move:
-7.98%
7 Day Trial
ALL ACCESS PASS
$
7
This tech company grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and KPTI is experiencing slight selling pressure.
Karyopharm Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.37 | Buy |
| 20-day SMA: | 4.54 | Buy |
| 50-day SMA: | 6.24 | Sell |
| 200-day SMA: | 10.48 | Sell |
| 8-day EMA: | 5.45 | Buy |
| 20-day EMA: | 5.17 | Buy |
| 50-day EMA: | 6.18 | Sell |
| 200-day EMA: | 10.4 | Sell |
Karyopharm Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 53.53 | Buy |
| Chaikin Money Flow: | -20974 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.82 - 5.66) | Buy |
| Bollinger Bands (100): | (5.76 - 10.96) | Sell |
Karyopharm Therapeutics Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Karyopharm Therapeutics Stock
Is Karyopharm Therapeutics Stock a Buy?
-
Karyopharm Therapeutics share price is 5.62 while KPTI 8-day simple moving average is 5.37, which is a Buy signal.
-
The stock price of KPTI is 5.62 while Karyopharm Therapeutics 20-day SMA is 4.54, which makes it a Buy.
-
Karyopharm Therapeutics 50-day simple moving average is 6.24 while KPTI share price is 5.62, making it a Sell technically.
-
KPTI stock price is 5.62 and Karyopharm Therapeutics 200-day simple moving average is 10.48, creating a Sell signal.
KPTI Technical Analysis vs Fundamental Analysis
Sell
40
Karyopharm Therapeutics (KPTI)
is a Sell
Is Karyopharm Therapeutics a Buy or a Sell?
-
Karyopharm Therapeutics stock is rated a SellThe current Karyopharm Therapeutics [KPTI] share price is $5.62. The Score for KPTI is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Karyopharm Therapeutics Stock Info
Market Cap:
47.3M
Price in USD:
5.62
Share Volume:
50.9K
Karyopharm Therapeutics 52-Week Range
52-Week High:
18.00
52-Week Low:
3.51
Sell
40
Karyopharm Therapeutics (KPTI)
is a Sell
Karyopharm Therapeutics Share Price Forecast
-
What is the Karyopharm Therapeutics stock price today?The Karyopharm Therapeutics stock price is 5.62 USD today.
-
Will KPTI stock go up or go down?Karyopharm Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Karyopharm Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Karyopharm Therapeutics is overvalued.
Is Karyopharm Therapeutics Stock a Buy?
-
Karyopharm Therapeutics share price is 5.62 while KPTI 8-day exponential moving average is 5.45, which is a Buy signal.
-
The stock price of KPTI is 5.62 while Karyopharm Therapeutics 20-day EMA is 5.17, which makes it a Buy.
-
Karyopharm Therapeutics 50-day exponential moving average is 6.18 while KPTI share price is 5.62, making it a Sell technically.
-
KPTI stock price is 5.62 and Karyopharm Therapeutics 200-day simple moving average is 10.40, creating a Sell signal.
Fundamental Analysis of Karyopharm Therapeutics
Is Karyopharm Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $1.00 per share, a decrease next quarter of $2.05 per share, a decrease this year of $1.95 per share, and an increase next year of $2.97 per share.
Technical Analysis of Karyopharm Therapeutics
Should I short Karyopharm Therapeutics stock?
-
KPTI Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Karyopharm Therapeutics is a Sell
-
Karyopharm Therapeutics Relative Strength Index (RSI) is 53.53, which suggest Karyopharm Therapeutics is overbought
-
The Bollinger Bands (25) for Karyopharm Therapeutics is (3.82 - 5.66), which suggest Karyopharm Therapeutics is a Sell
-
The Bollinger Bands (100) for Karyopharm Therapeutics is (5.76 - 10.96), which suggest Karyopharm Therapeutics is a Sell
* Karyopharm Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.